Pier 88 Investment Partners’s Evolent Health EVH Stock Holding History

Pier 88 Investment Partners’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-13,065	Closed	-$164K	–	100
2019 Q1	$164K	Sell	13,065 -11,865	-48%	-$188K	0.08%	86
2018 Q4	$497K	Buy	24,930 +2,315	+10%	+$53.6K	0.25%	57
2018 Q3	$642K	Sell	22,615 -7,320	-24%	-$175K	0.28%	51
2018 Q2	$630K	Buy	+29,935	New	+$567K	0.3%	50

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Pier 88 Investment Partners's EVH Position: Q2 2019 in Review

Pier 88 Investment Partners sold out of Evolent Health (EVH) in Q2 2019, closing a stake of 13,065 shares — an estimated $164K sold.

Pier 88 Investment Partners first reported a position in EVH in Q2 2018 and held it in 4 quarters. The position peaked at $642K in Q3 2018. 183 funds tracked by Wall St. Rank hold EVH as of Q2 2019.

Pier 88 Investment Partners reported no remaining Evolent Health position as of Q2 2019 after selling out during the quarter.
Pier 88 Investment Partners sold 13,065 Evolent Health shares in Q2 2019, an estimated $164K.
Pier 88 Investment Partners first reported a position in Evolent Health in Q2 2018 and held it in 4 quarters.
Pier 88 Investment Partners's Evolent Health position peaked at $642K in Q3 2018.
183 funds tracked by Wall St. Rank held Evolent Health as of Q2 2019.

Based on Pier 88 Investment Partners's 13F filing for Q2 2019, filed 8 Aug 2019.